Marathon Run under Chemotherapy: Is It Possible?

Publisher： Karger

E-ISSN： 2296-5262|34|5|259-261

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.34, Iss.5, 2011-04, pp. : 259-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Marathon Running During Chemotherapy: Where Are the Limits?

By  

Oncology Research and Treatment, Vol. 34, Iss. 5, 2011-04 ,pp. : 230-230

Karger

Access to resources Recommend Favorite

Troponin I measured with a high sensitivity immunoassay is significantly increased after a half marathon run

By Lippi Giuseppe   Schena Federico   Dipalo Mariella   Montagnana Martina   Salvagno Gian L.   Aloe Rosalia   Guidi Gian C.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 72, Iss. 6, 2012-10 ,pp. : 467-470

Informa Healthcare

Access to resources Recommend Favorite

Acute variation of biochemical markers of muscle damage following a 21-km, half-marathon run

By Lippi G.   Schena F.   Salvagno G. L.   Montagnana M.   Gelati M.   Tarperi C.   Banfi G.   Guidi G. C.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 68, Iss. 7, 2008-01 ,pp. : 667-672

Informa Healthcare

Access to resources Recommend Favorite

Reversible Foetal Cerebral Ventriculomegaly and Cardiomyopathy under Chemotherapy for Maternal AML

By  

Oncology Research and Treatment, Vol. 32, Iss. 1-2, 2009-01 ,pp. : 40-43

Karger

Access to resources Recommend Favorite

O-MAX Chemotherapy: High Activity in Metastatic Esophagogastric Adenocarcinoma and Possible Relation to Subclinical Hemolysis

By  

Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. : 371-380

Karger

Access to resources Recommend Favorite